[PDF][PDF] Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK …

M Yamaguchi, YL Kwong, WS Kim, Y Maeda… - J Clin …, 2011 - researchgate.net
Purpose To explore a more effective treatment for newly diagnosed stage IV, relapsed, or
refractory extranodal natural killer/T-cell lymphoma, nasal type (ENKL), we conducted a …

[PDF][PDF] Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211

M Yamaguchi, K Tobinai, M Oguchi… - Journal of clinical …, 2009 - academia.edu
Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell
Lymphoma: Japan Clinical Oncology Gro Page 1 Phase I/II Study of Concurrent …

Prospective measurement of Epstein-Barr virus–DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type

R Suzuki, M Yamaguchi, K Izutsu… - Blood, The Journal …, 2011 - ashpublications.org
Abstract Epstein-Barr virus (EBV)–DNA was prospectively analyzed in plasma and
mononuclear cells (MNCs) from peripheral blood in patients with extranodal natural killer …

Defective Epstein–Barr virus in chronic active infection and haematological malignancy

Y Okuno, T Murata, Y Sato, H Muramatsu, Y Ito… - Nature …, 2019 - nature.com
Epstein–Barr virus (EBV) infection is highly prevalent in humans and is implicated in various
diseases, including cancer,. Chronic active EBV infection (CAEBV) is an intractable disease …

Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211

M Yamaguchi, K Tobinai, M Oguchi… - Journal of Clinical …, 2012 - ascopubs.org
We agree with Charalambous and Silbermann1 that action needs to be taken to improve the
skills of oncologists to manage chronic cancer pain. Their suggestion for clinical training …

Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type

Y Ito, H Kimura, Y Maeda, C Hashimoto, F Ishida… - Clinical Cancer …, 2012 - AACR
Abstract Purpose: Extranodal NK/T-cell lymphoma, nasal type (ENKL) is an Epstein–Barr
virus (EBV)–associated lymphoma for which a new chemotherapeutic regimen called SMILE …

Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells

Y Isobe, K Sugimoto, L Yang, K Tamayose, M Egashira… - Cancer research, 2004 - AACR
Although considerable part of natural killer (NK) cell neoplasms possess EBV genome, there
has been no direct evidence that EBV infects human NK cells in vitro. In this study, we …

Aggressive natural killer cell leukemia: Therapeutic potential of l‐asparaginase and allogeneic hematopoietic stem cell transplantation

F Ishida, YH Ko, WS Kim, J Suzumiya, Y Isobe… - Cancer …, 2012 - Wiley Online Library
We conducted a retrospective J apan–K orea multicenter study to better elucidate the
clinicopathologic features and therapeutic modalities for aggressive natural killer cell …

Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome

M Okamoto, H Yamaguchi, Y Isobe, N Yokose… - Internal …, 2009 - jstage.jst.go.jp
Background/Aims Secondary hemophagocytic syndrome (hemophagocytic
lymphohistiocytosis, HLH) follows viral infection, malignant disorders, and autoimmune …

T/NK cell type chronic active Epstein–Barr virus disease in adults: an underlying condition for Epstein–Barr virus-associated T/NK-cell lymphoma

Y Isobe, N Aritaka, Y Setoguchi, Y Ito… - Journal of clinical …, 2012 - jcp.bmj.com
A chronic infectious mononucleosis-like illness caused by Epstein–Barr virus (EBV) is called
'chronic active EBV disease', which is defined as an EBV-associated lymphoproliferative …